Develop a 3D neurological disease model of human cortical glutamatergic neurons using micropillar-based scaffolds
KAUST DepartmentMaterial Science and Engineering Program
Physical Science and Engineering (PSE) Division
Online Publication Date2019-03-23
Print Publication Date2019-05
Permanent link to this recordhttp://hdl.handle.net/10754/652839
MetadataShow full item record
AbstractEstablishing an effective three-dimensional (3D) in vitro culture system to better model human neurological diseases is desirable, since the human brain is a 3D structure. Here, we demonstrated the development of a polydimethylsiloxane (PDMS) pillar-based 3D scaffold that mimicked the 3D microenvironment of the brain. We utilized this scaffold for the growth of human cortical glutamatergic neurons that were differentiated from human pluripotent stem cells. In comparison with the 2D culture, we demonstrated that the developed 3D culture promoted the maturation of human cortical glutamatergic neurons by showing significantly more MAP2 and less Ki67 expression. Based on this 3D culture system, we further developed an in vitro disease-like model of traumatic brain injury (TBI), which showed a robust increase of glutamate-release from the neurons, in response to mechanical impacts, recapitulating the critical pathology of TBI. The increased glutamate-release from our 3D culture model was attenuated by the treatment of neural protective drugs, memantine or nimodipine. The established 3D in vitro human neural culture system and TBI-like model may be used to facilitate mechanistic studies and drug screening for neurotrauma or other neurological diseases.
CitationChen C, Dong X, Fang K-H, Yuan F, Hu Y, et al. (2019) Develop a 3D neurological disease model of human cortical glutamatergic neurons using micropillar-based scaffolds. Acta Pharmaceutica Sinica B. Available: http://dx.doi.org/10.1016/j.apsb.2019.03.004.
SponsorsThis study was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA16010306), the National Natural Science Foundation of China Grants (91849117 and 81471301), Key Research and Development Program of China (2016YFC1306703), The National Jiangsu Outstanding Young Investigator Program (BK20160044, China), Jiangsu Province׳s Innovation Person (China), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China Project (Grant No. 17KJB180010).
JournalActa Pharmaceutica Sinica B
Except where otherwise noted, this item's license is described as This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).